サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1504997

非侵襲的出生前検査市場、シェア、規模、動向、産業分析レポート：妊娠期間別、構成別、方法別、用途別、最終用途別、地域別、セグメント別予測、2024年～2032年

Non-Invasive Prenatal Testing Market Share, Size, Trends, Industry Analysis Report, By Gestation Period; By Component; By Method; By Application; By End-Use; By Regions; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
非侵襲的出生前検査市場、シェア、規模、動向、産業分析レポート：妊娠期間別、構成別、方法別、用途別、最終用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年05月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界の非侵襲的出生前検査（NIPT）市場規模は2032年までに101億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

非侵襲的出生前検査の市場需要は、遺伝性疾患の発生率の増加、早期胎児検査に関する意識の高まり、妊産婦年齢の上昇により、予測期間中に増加すると予想されます。医療インフラの著しい市場成長、技術の進歩、有利な規制は、予測期間中に成長機会を提供すると期待されるいくつかの要因です。

妊娠期間セグメントは、0～12週、13～24週、25～36週に分けられています。13～24週に実施される検査には、遺伝的疾患や神経管欠損を検出するための血液検査や超音波検査が含まれます。また、この時期には解剖学的構造や関連する障害を調べるために超音波検査が行われます。非侵襲的出生前検査に必要な消耗品の需要は高いです。胎児検査に関する意識の高まりは、技術の進歩、政府の支援的な規制、先進的な医療インフラと相まって、市場の成長を後押ししています。

非侵襲的出生前検査は、モノソミー、トリソミー、微小欠失症候群、その他の検出に使用されます。トリソミーの検出精度の高さ、母体年齢の上昇、早期かつ非侵襲的な胎児診断に関する意識の高まりにより、トリソミーは非侵襲的出生前検査の世界市場で大きなシェアを占めています。トリソミー検出のための検査は、21番、18番、13番染色体を含む3つの一般的なトリソミーを検出するための安全性、信頼性、精度を高めるために10週以降に実施されます。

非侵襲的出生前検査のさまざまな方法には、母体血漿中の無細胞DNA検査、超音波検査、生化学的スクリーニング検査などがあります。母体血漿中の無細胞DNAセグメントは予測期間中に大きく成長すると予想されます。この方法による染色体異常の検出精度の向上、患者の意識の高まり、妊娠管理のための効率的な計画などが、このセグメントの成長を促進する要因です。

非侵襲的出生前検査サービスは、診断センター、病院、クリニック、その他で提供されています。診断センター部門は2020年に最も高いシェアを占めました。染色体異常の発生件数の増加と政府の支援策がこのセグメントの成長を支えています。専門機器、先進医療インフラ、専門家の存在が、患者が診断センターを訪れることをさらに後押ししています。

北米は2020年に世界のNIPT市場を席巻し、予測期間中もその優位性を維持すると予想されます。高い生活水準、医療サービスへの多額の投資、染色体異常の増加などがこの地域の市場成長を支えています。しかし、アジア太平洋は予測期間中に著しい成長を示すと予想されます。人口の増加と胎児検査に関する意識の高まりが、この地域の成長を促進しています。世界の主要企業は、中国、日本、インド、韓国の発展途上国でのプレゼンスを拡大し、これらの国々が提供する成長機会を利用しています。

技術の進歩や顧客の要求に応える必要性の高まりから、各社は市場での存在感を強め、市場シェアを獲得するために協力しています。製品ポートフォリオの拡大も、この業界に見られる動向のひとつです。

主要市場参入企業には、Agilent Technologies, Inc.、Laboratory Corporation of America Holdings、Illumina, Inc.、F. Hoffman-La Roche Ltd.、Yourgene Health、Perkinelmer, Inc.、GE Healthcare、Quest Diagnostics、Thermo Fisher Scientific, Inc.、Sequenom、Qiagen N.V.、Koninklijke Philips N.V.、Natera, Inc.、Beijing Genomics Institute、Pacific Biosciences of California, Inc.などがあります。

第1章 目次

第2章 イントロダクション

第3章 エグゼクティブ概要

第4章 調査手法

第5章 非侵襲的出生前検査市場洞察

  • 非侵襲的出生前検査-業界概要
  • 非侵襲的出生前検査市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • PESTLE分析
  • 非侵襲的出生前検査市場業界動向

第6章 妊娠期間別の非侵襲的出生前検査市場評価

  • 主要調査結果
  • イントロダクション
    • 世界の非侵襲的出生前検査市場、妊娠期間別、2016～2028年
  • 0～12週間
    • 世界の非侵襲的出生前検査市場、0～12週間別、地域別、2016～2028年
  • 13～24週間
    • 世界の非侵襲的出生前検査市場、13～24週別、地域別、2016～2028年
  • 25～36週
    • 世界の非侵襲的出生前検査市場、25～36週別、地域別、2016～2028年

第7章 世界の非侵襲的出生前検査市場：構成別

  • 主要調査結果
  • イントロダクション
  • 消耗品
  • 機器
  • ソフトウェア
  • サービス

第8章 世界の非侵襲的出生前検査市場：用途別

  • 主要調査結果
  • イントロダクション
  • モノソミー
  • トリソミー
  • 微小欠失症候群
  • その他

第9章 方法別の非侵襲的出生前検査市場評価

  • 主要調査結果
  • イントロダクション
    • 世界の非侵襲的出生前検査市場、方法別、2016～2028年
  • 母体血漿検査における遊離DNA
    • 世界の非侵襲的出生前検査市場、母体血漿検査における細胞遊離DNA別、地域別、2016～2028年
  • 超音波検出
    • 世界の非侵襲的出生前検査市場、超音波検出別、地域別、2016～2028年
  • 生化学スクリーニング検査
    • 世界の非侵襲的出生前検査市場、生化学スクリーニング検査別、地域別、2016～2028年
  • その他
    • 世界の非侵襲的出生前検査市場、その他、地域別、2016～2028年

第10章 世界の非侵襲的出生前検査市場：最終用途別

  • 主要調査結果
  • イントロダクション
  • 診断センター
  • 病院
  • クリニック
  • その他

第11章 地域別の非侵襲的出生前検査市場評価

  • 主要調査結果
  • イントロダクション
    • 非侵襲的出生前検査市場評価：地域、2016～2028年
  • 北米
    • 北米：妊娠期間別、2016～2028年
    • 北米：構成別、2016～2028年
    • 北米：用途別、2016～2028年
    • 北米：方法別、2016～2028年
    • 北米：最終用途別、2016～2028年
    • 米国
      • 米国：妊娠期間別、2016～2028年
      • 米国：構成別、2016～2028年
      • 米国：用途別、2016～2028年
      • 米国：方法別、2016～2028年
      • 米国：最終用途別、2016～2028年
    • カナダ
      • カナダ：妊娠期間別、2016～2028年
      • カナダ：構成別、2016～2028年
      • カナダ：申請別、2016～2028年
      • カナダ：方法別、2016～2028年
      • カナダ：最終用途別、2016～2028年
  • 欧州
    • 欧州：妊娠期間別、2016～2028年
    • 欧州：構成別、2016～2028年
    • 欧州：用途別、2016～2028年
    • 欧州：方法別、2016～2028年
    • 欧州：最終用途別、2016～2028年
    • 英国
      • 英国：妊娠期間別、2016～2028年
      • 英国：構成別、2016～2028年
      • 英国：用途別、2016～2028年
      • 英国：方法別、2016～2028年
      • 英国：最終用途別、2016～2028年
    • フランス
      • フランス：妊娠期間別、2016～2028年
      • フランス：構成別、2016～2028年
      • フランス：用途別、2016～2028年
      • フランス：方法別、2016～2028年
      • フランス：最終用途別、2016～2028年
    • ドイツ
      • ドイツ：妊娠期間別、2016～2028年
      • ドイツ：構成別、2016～2028年
      • ドイツ：用途別、2016～2028年
      • ドイツ：方法別、2016～2028年
      • ドイツ：最終用途別、2016～2028年
    • イタリア
      • イタリア：妊娠期間別、2016～2028年
      • イタリア：構成別、2016～2028年
      • イタリア：用途別、2016～2028年
      • イタリア：方法別、2016～2028年
      • イタリア：最終用途別、2016～2028年
    • スペイン
      • スペイン：妊娠期間別、2016～2028年
      • スペイン：構成別、2016～2028年
      • スペイン：用途別、2016～2028年
      • スペイン：方法別、2016～2028年
      • スペイン：最終用途別、2016～2028年
    • その他の欧州
      • その他の欧州：妊娠期間別、2016～2028年
      • その他の欧州：構成別、2016～2028年
      • その他の欧州：用途別、2016～2028年
      • その他の欧州：方法別、2016～2028年
      • その他の欧州：最終用途別、2016～2028年
  • アジア太平洋
    • アジア太平洋：妊娠期間別、2016～2028年
    • アジア太平洋：構成別、2016～2028年
    • アジア太平洋：用途別、2016～2028年
    • アジア太平洋：方法別、2016～2028年
    • アジア太平洋：最終用途別、2016～2028年
    • 中国
      • 中国：妊娠期間別、2016～2028年
      • 中国：構成別、2016～2028年
      • 中国：用途別、2016～2028年
      • 中国：方法別、2016～2028年
      • 中国：最終用途別、2016～2028年
    • インド
      • インド：妊娠期間別、2016～2028年
      • インド：構成別、2016～2028年
      • インド：用途別、2016～2028年
      • インド：方法別、2016～2028年
      • インド：最終用途別、2016～2028年
    • 韓国
      • 韓国：妊娠期間別、2016～2028年
      • 韓国：構成別、2016～2028年
      • 韓国：用途別、2016～2028年
      • 韓国：方法別、2016～2028年
      • 韓国：最終用途別、2016～2028年
    • 日本
      • 日本：妊娠期間別、2016～2028年
      • 日本：構成別、2016～2028年
      • 日本：用途別、2016～2028年
      • 日本：方法別、2016～2028年
      • 日本：最終用途別、2016～2028年
    • アジア太平洋
      • Roアジア太平洋：妊娠期間別、2016～2028年
      • Roアジア太平洋：構成別、2016～2028年
      • Roアジア太平洋：用途別、2016～2028年
      • Roアジア太平洋：方法別、2016～2028年
      • Roアジア太平洋：最終用途別、2016～2028年
  • 中東・アフリカ
    • 中東・アフリカ：妊娠期間別、2016～2028年
    • 中東・アフリカ：構成別、2016～2028年
    • 中東・アフリカ：用途別、2016～2028年
    • 中東・アフリカ：方法別、2016～2028年
    • 中東・アフリカ：最終用途別、2016～2028年
    • サウジアラビア
      • サウジアラビア：妊娠期間別、2016～2028年
      • サウジアラビア：構成別、2016～2028年
      • サウジアラビア：用途別、2016～2028年
      • サウジアラビア：方法別、2016～2028年
      • サウジアラビア：最終用途別、2016～2028年
    • アラブ首長国連邦
      • アラブ首長国連邦：妊娠期間別、2016～2028年
      • アラブ首長国連邦：構成別、2016～2028年
      • アラブ首長国連邦：用途別、2016～2028年
      • アラブ首長国連邦：方法別、2016～2028年
      • アラブ首長国連邦：最終用途別、2016～2028年
    • イスラエル
      • イスラエル：妊娠期間別、2016～2028年
      • イスラエル：構成別、2016～2028年
      • イスラエル：用途別、2016～2028年
      • イスラエル：方法別、2016～2028年
      • イスラエル：最終用途別、2016～2028年
    • 南アフリカ
      • 南アフリカ：妊娠期間別、2016～2028年
      • 南アフリカ：構成別、2016～2028年
      • 南アフリカ：用途別、2016～2028年
      • 南アフリカ：方法別、2016～2028年
      • 南アフリカ：最終用途別、2016～2028年
    • その他の中東・アフリカ
      • その他の中東・アフリカ：妊娠期間別、2016～2028年
      • その他の中東・アフリカ：構成別、2016～2028年
      • その他の中東・アフリカ：用途別、2016～2028年
      • その他の中東・アフリカ：方法別、2016～2028年
      • その他の中東・アフリカ：最終用途別、2016～2028年
  • ラテンアメリカ
    • ラテンアメリカ：妊娠期間別、2016～2028年
    • ラテンアメリカ：構成別、2016～2028年
    • ラテンアメリカ：用途別、2016～2028年
    • ラテンアメリカ：方法別、2016～2028年
    • ラテンアメリカ：最終用途別、2016～2028年
    • メキシコ
      • メキシコ：妊娠期間別、2016～2028年
      • メキシコ：構成別、2016～2028年
      • メキシコ：用途別、2016～2028年
      • メキシコ：方法別、2016～2028年
      • メキシコ：最終用途別、2016～2028年
    • ブラジル
      • ブラジル：妊娠期間別、2016～2028年
      • ブラジル：構成別、2016～2028年
      • ブラジル：用途別、2016～2028年
      • ブラジル：方法別、2016～2028年
      • ブラジル：最終用途別、2016～2028年
    • コロンビア
      • コロンビア：妊娠期間別、2016～2028年
      • コロンビア：構成別、2016～2028年
      • コロンビア：用途別、2016～2028年
      • コロンビア：方法別、2016～2028年
      • コロンビア：最終用途別、2016～2028年
    • その他のラテンアメリカ
      • その他のラテンアメリカ：妊娠期間別、2016～2028年
      • その他のラテンアメリカ：構成別、2016～2028年
      • その他のラテンアメリカ：用途別、2016～2028年
      • その他のラテンアメリカ：方法別、2016～2028年
      • その他のラテンアメリカ：最終用途別、2016～2028年

第12章 競合情勢

  • 拡大と買収の分析
    • 拡大
  • 提携/協業/合意/公開

第13章 企業プロファイル

  • Agilent Technologies, Inc.
  • Laboratory Corporation of America Holdings
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • Yourgene Health
  • Perkinelmer, Inc.
  • GE Healthcare
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Sequenom
図表

List of Tables

  • Table 1 Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 2 Global Non-Invasive Prenatal Testing (NIPT) Market, by Component, by Region, 2016 - 2028 (USD Million)
  • Table 3 Global Non-Invasive Prenatal Testing (NIPT) Market, by Application, by Region, 2016 - 2028 (USD Million)
  • Table 4 Global Non-Invasive Prenatal Testing (NIPT) Market, by Method, by Region, 2016 - 2028 (USD Million)
  • Table 5 Global Non-Invasive Prenatal Testing (NIPT) Market, by End-Use, by Region, 2016 - 2028 (USD Million)
  • Table 6 Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Table 7 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 8 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 9 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 10 North America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 11 North America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 12 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 13 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 14 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 15 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 16 U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 17 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 18 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 19 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 20 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 21 Canada: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 22 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 23 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 24 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 25 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 26 Europe: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 27 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 28 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 29 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 30 UK: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 31 UK: Non-Invasive Prenatal Testing (NIPT) Market, By End-Uses, 2016 - 2028 (USD Million)
  • Table 32 France: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 33 France: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 34 France: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 35 France: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 36 France: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 37 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 38 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 39 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 40 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 41 Germany: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 42 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 43 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 44 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 45 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 46 Italy: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 47 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 48 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 49 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 50 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 51 Netherlands: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 52 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 53 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 54 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 55 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 56 Austria: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 57 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 58 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 59 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 60 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 61 Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 62 China: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 63 China: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 64 China: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 65 China: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 66 China: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 67 India: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 68 India: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 69 India: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 70 India: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 71 India: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 72 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 73 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 74 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 75 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 76 Japan: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 77 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 78 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 79 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 80 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 81 Malaysia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 82 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 83 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 84 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 85 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 86 Indonesia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 87 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 88 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 89 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 90 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 91 South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By End-Uses, 2016 - 2028 (USD Million)
  • Table 92 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 93 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 94 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 95 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 96 Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 97 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 98 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 99 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 100 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 101 Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 102 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 103 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 104 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 105 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 106 Israel: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 107 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 108 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 109 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 110 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 111 South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 112 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 113 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 114 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 115 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 116 Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 117 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 118 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 119 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 120 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 121 Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 122 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 123 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 124 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 125 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 126 Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • Table 127 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • Table 128 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • Table 129 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • Table 130 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • Table 131 Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2020, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Component
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Gestation Period
  • Figure 7. Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2020 & 2028 (USD Million)
  • Figure 8. Market by Component
  • Figure 9. Global Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2020 & 2028 (USD Million)
  • Figure 10. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2020 & 2028 (USD Million)
  • Figure 11. Market by Method
  • Figure 12. Global Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2020 & 2028 (USD Million)
  • Figure 13. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • Figure 14. Strategic Analysis - Non-Invasive Prenatal Testing (NIPT) Market
目次
Product Code: PM1836

The global non-invasive prenatal testing (NIPT) market size is expected to reach USD 10.10 billion by 2032 according to a new study by Polaris Market Research. The report "Non-Invasive Prenatal Testing (NIPT) Market Share, Size, Trends, Industry Analysis Report, By Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks); By Component (Consumables, Instruments, Software, Services); By Method; By Application; By End-Use; By Regions; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market demand for non-invasive prenatal testing is expected to increase during the forecast period owing to growth in the occurrence of genetic disorders, increasing awareness regarding early fetal testing, and advancing maternal age. The significant market growth in healthcare infrastructure, technological advancements, and favorable regulations are some factors expected to provide growth opportunities during the forecast period.

The gestation period segment has been divided into 0-12 weeks, 13-24 weeks, 25-36 weeks. Testing performed for 13 - 24 weeks involves blood tests and ultrasound to detect genetic disorders and neural tube defects. Ultrasounds are also used in this period to examine the anatomy and associated disorders. There has been a high demand for consumables required during non-invasive prenatal testing. The rising awareness regarding fetal testing, coupled with technological advancements, supportive government regulations, and advanced healthcare infrastructure boosts the market growth.

Non-invasive prenatal testing is used for the detection of Monosomy, Trisomy, Microdeletion Syndrome, and Others. The trisomy accounted for a major share of the global market for non-invasive prenatal testing owing to high accuracy in detection of trisomy, growing maternal age, and increasing awareness regarding early and non-invasive fetal diagnosis. The test for detection of trisomy is performed after 10 weeks for enhanced safety, reliability, and accuracy for detection of the three common trisomy including chromosomes 21, 18, and 13.

The different methods of non-invasive prenatal testing include cell-free DNA in maternal plasma tests, ultrasound detection, biochemical screening tests, and others. The cell-free DNA in the maternal plasma segment is expected to grow significantly during the forecast period. The increasing accuracy in the detection of chromosomal abnormalities through this method, growing patient awareness, and efficient planning for pregnancy management are some factors driving the growth of this segment.

Non-invasive prenatal testing services are offered in diagnostic centers, hospitals, clinics, and others. The diagnostic centers segment accounted for the highest share in 2020. The increasing occurrence of chromosomal abnormalities coupled with supportive government initiatives supports the growth of this segment. The presence of specialized equipment, advanced healthcare infrastructure, and expert professionals further encourage patients to visit diagnostic centers.

North America dominated the global NIPT market in 2020 and is expected to maintain its dominance over the forecast period. High living standards, significant investment in healthcare services, and increasing occurrence of chromosome abnormalities support market growth in this region. However, Asia-Pacific is expected to exhibit significant growth during the forecast period. Increasing population coupled with increasing awareness regarding fetal testing fuels growth in this region. Leading global players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries.

On account of the technological advancements, and greater need to cater to customer requirements, companies are collaborating in order to strengthen the market presence and gain market share. Broadening of the product portfolio is another trend that is visible in the industry.

Some of the major market participants include Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Illumina, Inc., F. Hoffman-La Roche Ltd., Yourgene Health, Perkinelmer, Inc., GE Healthcare, Quest Diagnostics, Thermo Fisher Scientific, Inc., Sequenom, Qiagen N.V., Koninklijke Philips N.V., Natera, Inc., Beijing Genomics Institute, and Pacific Biosciences of California, Inc.

Polaris Market Research has segmented the non-invasive prenatal testing (NIPT) market report on the basis of gestation period, component, method, application, end-use, and region:

Non-Invasive Prenatal Testing (NIPT) Gestation Period Outlook (Revenue, USD Million, 2016 - 2028)

  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks

Non-Invasive Prenatal Testing (NIPT) Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Consumables
  • Instruments
  • Software
  • Services

Non-Invasive Prenatal Testing (NIPT) Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Monosomy
  • Trisomy
  • Microdeletion Syndrome
  • Others

Non-Invasive Prenatal Testing (NIPT) Method Outlook (Revenue, USD Million, 2016 - 2028)

  • Cell-Free DNA in Maternal Plasma Tests
  • Ultrasound Detection
  • Biochemical Screening Tests
  • Others

Non-Invasive Prenatal Testing (NIPT) End-Use Outlook (Revenue, USD Million, 2016 - 2028)

  • Diagnostic Centers
  • Hospitals
  • Clinics
  • Others

Non-Invasive Prenatal Testing (NIPT) Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • RoLATAM
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • UAE
  • RoMEA

1. Table of Contents

2. Introduction

  • 2.1. Report Description
    • 2.1.1. Objectives of the Study
    • 2.1.2. Market Scope
    • 2.1.3. Assumptions
  • 2.2. Stakeholders

3. Executive Summary

  • 3.1. Market Highlights

4. Research Methodology

  • 4.1. Overview
    • 4.1.1. Data Mining
  • 4.2. Data Sources
    • 4.2.1. Primary Sources
    • 4.2.2. Secondary Sources

5. Non-Invasive Prenatal Testing (NIPT) Market Insights

  • 5.1. Non-Invasive Prenatal Testing (NIPT) - Industry snapshot
  • 5.2. Non-Invasive Prenatal Testing (NIPT) Market Dynamics
    • 5.2.1. Drivers and Opportunities
    • 5.2.2. Restraints and Challenges
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining Power of Suppliers (Moderate)
    • 5.3.2. Threats of New Entrants: (Low)
    • 5.3.3. Bargaining Power of Buyers (Moderate)
    • 5.3.4. Threat of Substitute (Moderate)
    • 5.3.5. Rivalry among existing firms (High)
  • 5.4. PESTLE Analysis
  • 5.5. Non-Invasive Prenatal Testing (NIPT) Market Industry trends

6. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Gestation Period

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
  • 6.3. 0-12 weeks
    • 6.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 0-12 weeks, by Region, 2016 - 2028 (USD Million
  • 6.4. 13-24 weeks
    • 6.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 13-24 weeks, by Region, 2016 - 2028 (USD Million)
  • 6.5. 25-36 weeks
    • 6.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by 25-36 weeks, by Region, 2016 - 2028 (USD Million)

7. Global Non-Invasive Prenatal Testing (NIPT) Market, by Component

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
  • 7.3. Consumables
    • 7.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Consumables, By Region, 2016 - 2028 (USD Million)
  • 7.4. Instruments
    • 7.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Instruments, by Region, 2016 - 2028 (USD Million)
  • 7.5. Software
    • 7.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Software, by Region, 2016 - 2028 (USD Million)
  • 7.6. Services
    • 7.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Services, by Region, 2016 - 2028 (USD Million)

8. Global Non-Invasive Prenatal Testing (NIPT) Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
  • 8.3. Monosomy
    • 8.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Monosomy, By Region, 2016 - 2028 (USD Million)
  • 8.4. Trisomy
    • 8.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Trisomy, by Region, 2016 - 2028 (USD Million)
  • 8.5. Microdeletion Syndrome
    • 8.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Microdeletion Syndrome, by Region, 2016 - 2028 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other Applications, by Region, 2016 - 2028 (USD Million)

9. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Method

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
  • 9.3. Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Cell-Free DNA in Maternal Plasma Tests, by Region, 2016 - 2028 (USD Million)
  • 9.4. Ultrasound Detection
    • 9.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Ultrasound Detection, by Region, 2016 - 2028 (USD Million)
  • 9.5. Biochemical Screening Tests
    • 9.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Biochemical Screening Tests, by Region, 2016 - 2028 (USD Million)
  • 9.6. Others
    • 9.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Others, by Region, 2016 - 2028 (USD Million)

10. Global Non-Invasive Prenatal Testing (NIPT) Market, by End-Use

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 10.3. Diagnostic Centers
    • 10.3.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Diagnostic Centers, By Region, 2016 - 2028 (USD Million)
  • 10.4. Hospitals
    • 10.4.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Hospitals, by Region, 2016 - 2028 (USD Million)
  • 10.5. Clinics
    • 10.5.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Clinics, by Region, 2016 - 2028 (USD Million)
  • 10.6. Others
    • 10.6.1. Global Non-Invasive Prenatal Testing (NIPT) Market, by Other End-Uses, by Region, 2016 - 2028 (USD Million)

11. Non-Invasive Prenatal Testing (NIPT) Market Assessment by Geography

  • 11.1. Key findings
  • 11.2. Introduction
    • 11.2.1. Non-Invasive Prenatal Testing (NIPT) Market Assessment, By Geography, 2016 - 2028 (USD Million)
  • 11.3. Non-Invasive Prenatal Testing (NIPT) Market - North America
    • 11.3.1. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.3.2. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.3.3. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.3.4. North America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.3.5. North America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.3.6. Non-Invasive Prenatal Testing (NIPT) Market - U.S.
      • 11.3.6.1. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.3.6.2. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.3.6.3. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.3.6.4. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.3.6.5. U.S.: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.3.7. Non-Invasive Prenatal Testing (NIPT) Market - Canada
      • 11.3.7.1. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.3.7.2. Canada.: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.3.7.3. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.3.7.4. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.3.7.5. Canada: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.4. Non-Invasive Prenatal Testing (NIPT) Market - Europe
    • 11.4.1. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.4.2. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.4.3. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.4.4. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.4.5. Europe: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.6. Non-Invasive Prenatal Testing (NIPT) Market - UK
      • 11.4.6.1. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.6.2. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.6.3. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.6.4. UK: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.6.5. UK: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.7. Non-Invasive Prenatal Testing (NIPT) Market - France
      • 11.4.7.1. France: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.7.2. France: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.7.3. France: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.7.4. France: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.7.5. France: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.8. Non-Invasive Prenatal Testing (NIPT) Market - Germany
      • 11.4.8.1. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.8.2. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.8.3. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.8.4. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.8.5. Germany: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.9. Non-Invasive Prenatal Testing (NIPT) Market - Italy
      • 11.4.9.1. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.9.2. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.9.3. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.9.4. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.9.5. Italy: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.10. Non-Invasive Prenatal Testing (NIPT) Market - Spain
      • 11.4.10.1. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.10.2. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.10.3. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.10.4. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.10.5. Spain: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.4.11. Non-Invasive Prenatal Testing (NIPT) Market - RoE
      • 11.4.11.1. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.4.11.2. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.4.11.3. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.4.11.4. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.4.11.5. RoE: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.5. Non-Invasive Prenatal Testing (NIPT) Market - Asia-Pacific
    • 11.5.1. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.5.2. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.5.3. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.5.4. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.5.5. Asia Pacific: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.6. Non-Invasive Prenatal Testing (NIPT) Market - China
      • 11.5.6.1. China: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.6.2. China: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.6.3. China: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.6.4. China: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.6.5. China: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.7. Non-Invasive Prenatal Testing (NIPT) Market - India
      • 11.5.7.1. India: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.7.2. India: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.7.3. India: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.7.4. India: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.7.5. India: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.8. Non-Invasive Prenatal Testing (NIPT) Market - South Korea
      • 11.5.8.1. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.8.2. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.8.3. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.8.4. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.8.5. South Korea: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.9. Non-Invasive Prenatal Testing (NIPT) Market - Japan
      • 11.5.9.1. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.9.2. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.9.3. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.9.4. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.9.5. Japan: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.5.10. Non-Invasive Prenatal Testing (NIPT) Market - RoAPAC
      • 11.5.10.1. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.5.10.2. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.5.10.3. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.5.10.4. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.5.10.5. RoAPAC: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.6. Non-Invasive Prenatal Testing (NIPT) Market - Middle East & Africa
    • 11.6.1. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.6.2. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.6.3. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.6.4. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.6.5. Middle East & Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.6. Non-Invasive Prenatal Testing (NIPT) Market - Saudi Arabia
      • 11.6.6.1. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.6.2. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.6.3. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.6.4. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.6.5. Saudi Arabia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.7. Non-Invasive Prenatal Testing (NIPT) Market - UAE
      • 11.6.7.1. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.7.2. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.7.3. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.7.4. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.7.5. UAE: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.8. Non-Invasive Prenatal Testing (NIPT) Market - Israel
      • 11.6.8.1. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.8.2. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.8.3. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.8.4. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.8.5. Israel: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.9. Non-Invasive Prenatal Testing (NIPT) Market - South Africa
      • 11.6.9.1. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.9.2. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.9.3. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.9.4. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.9.5. South Africa: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.6.10. Non-Invasive Prenatal Testing (NIPT) Market - RoMEA
      • 11.6.10.1. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.6.10.2. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.6.10.3. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.6.10.4. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.6.10.5. RoMEA: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
  • 11.7. Non-Invasive Prenatal Testing (NIPT) Market - Latin America
    • 11.7.1. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
    • 11.7.2. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
    • 11.7.3. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
    • 11.7.4. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
    • 11.7.5. Latin America: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.6. Non-Invasive Prenatal Testing (NIPT) Market - Mexico
      • 11.7.6.1. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.6.2. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.6.3. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.6.4. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.6.5. Mexico: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.7. Non-Invasive Prenatal Testing (NIPT) Market - Brazil
      • 11.7.7.1. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.7.2. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.7.3. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.7.4. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.7.5. Brazil: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.8. Non-Invasive Prenatal Testing (NIPT) Market - Colombia
      • 11.7.8.1. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.8.2. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.8.3. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.8.4. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.8.5. Colombia: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)
    • 11.7.9. Non-Invasive Prenatal Testing (NIPT) Market - RoLATAM
      • 11.7.9.1. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Gestation Period, 2016 - 2028 (USD Million)
      • 11.7.9.2. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Component, 2016 - 2028 (USD Million)
      • 11.7.9.3. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Application, 2016 - 2028 (USD Million)
      • 11.7.9.4. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By Method, 2016 - 2028 (USD Million)
      • 11.7.9.5. RoLATAM: Non-Invasive Prenatal Testing (NIPT) Market, By End-Use, 2016 - 2028 (USD Million)

12. Competitive Landscape

  • 12.1. Expansion and Acquisition Analysis
    • 12.1.1. Expansion
  • 12.2. Partnerships/Collaborations/Agreements/Exhibitions

13. Company Profiles

  • 13.1. Agilent Technologies, Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial PerMethodance
    • 13.1.3. Product Benchmarking
    • 13.1.4. Recent Development
  • 13.2. Laboratory Corporation of America Holdings
    • 13.2.1. Company Overview
    • 13.2.2. Financial PerMethodance
    • 13.2.3. Product Benchmarking
    • 13.2.4. Recent Development
  • 13.3. Illumina, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial PerMethodance
    • 13.3.3. Product Benchmarking
    • 13.3.4. Recent Development
  • 13.4. F. Hoffman-La Roche Ltd.
    • 13.4.1. Company Overview
    • 13.4.2. Financial PerMethodance
    • 13.4.3. Product Benchmarking
    • 13.4.4. Recent Development
  • 13.5. Yourgene Health
    • 13.5.1. Company Overview
    • 13.5.2. Financial PerMethodance
    • 13.5.3. Product Benchmarking
    • 13.5.4. Recent Development
  • 13.6. Perkinelmer, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial PerMethodance
    • 13.6.3. Product Benchmarking
    • 13.6.4. Recent Development
  • 13.7. GE Healthcare
    • 13.7.1. Company Overview
    • 13.7.2. Financial PerMethodance
    • 13.7.3. Product Benchmarking
    • 13.7.4. Recent Development
  • 13.8. Quest Diagnostics
    • 13.8.1. Company Overview
    • 13.8.2. Financial PerMethodance
    • 13.8.3. Product Benchmarking
    • 13.8.4. Recent Development
  • 13.9. Thermo Fisher Scientific, Inc.
    • 13.9.1. Company Overview
    • 13.9.2. Financial PerMethodance
    • 13.9.3. Product Benchmarking
    • 13.9.4. Recent Development
  • 13.10. Sequenom
    • 13.10.1. Company Overview
    • 13.10.2. Financial PerMethodance
    • 13.10.3. Product Benchmarking
    • 13.10.4. Recent Development